http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109666070-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 |
| filingDate | 2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109666070-B |
| titleOfInvention | Monoclonal antibody MERS-4V2 and coding gene and application thereof |
| abstract | The invention discloses a monoclonal antibody MERS-4V2, and a coding gene and application thereof. The invention provides a monoclonal antibody MERS-4V2, which is an IgG antibody and consists of a heavy chain and a light chain; CDR1, CDR2 and CDR3 in the heavy chain variable region in the heavy chain are the 45 th-52 th amino acid residue, the 70 th-77 th amino acid residue and the 116 th-120 th amino acid residue from the N terminal of the sequence 1 in the sequence table in sequence; the CDR1, CDR2 and CDR3 in the light chain variable region in the light chain are the 45 th-52 th amino acid residue, the 70 th-72 th amino acid residue and the 109 th-119 th amino acid residue from the N terminal of the sequence 3 in the sequence table in sequence. The invention also protects the application of the IgG antibody in preparing a medicament for inhibiting middle east respiratory syndrome coronavirus. The invention has wide application prospect in the development of medicaments (vaccines) for treating and/or preventing novel coronavirus MERS-CoV. |
| priorityDate | 2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 437.